Meeting
2021 Genitourinary Cancers Symposium
The impact of a positive family history on clinical and pathologic outcomes of active surveillance for prostate cancer.
Authors
Adam Schneider
Department of Urology, Thomas Jefferson University, Philadelphia, PA
Adam Schneider , Nicholas Bowler , Ryan Fogg , Joon Yau Leong , Andrew Gusev , Douglas M. Dahl , Jason A. Efstathiou , Michael L. Blute , Anthony L. Zietman , Adam S. Feldman , Thenappan Chandrasekar , Keyan Salari
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Localized Disease
Track
Prostate Cancer - Localized
Sub Track
Prevention, Screening, and Hereditary Cancers
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 225)
DOI
10.1200/JCO.2021.39.6_suppl.225
Abstract #
225
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
p2PSA-associated parameters are significant predictors of reclassification of first-year protocol biopsy on active surveillance for early-stage prostate cancer patients: From the PRIAS-JAPAN study.
First Author: Takuma Kato
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg
Poster
2018 Genitourinary Cancers Symposium
P53 as a predictor of clinical outcome in localized prostate cancer.
First Author: Kate Lynette Mahon
Poster
2017 Genitourinary Cancers Symposium
Validation of a 17-Gene Genomic Prostate Score (GPS) as a predictor of biochemical recurrence (BCR) in men with prostate cancer treated with radical prostatectomy (RP) in a community setting.
First Author: Stephen K. VanDenEeden